In the case of patients with uncontrolled GH/IGF-1 levels or severe hypercortisolism, caution and careful monitoring is needed when using SGLT-2 inhibitors due to the increased risk of diabetic ketoacidosis and genitourinary fungal infections (69, 70). The gene discussed is IGF1; the disease is adrenal gland hyperfunction.